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Caprine Arthritis Encephalitis (CAE) is a disease negatively affecting goats, around the world. A 
mutation on the CCR5-gene has showed an increase in viral load.  
CAE is a lentivirus that affects the monocytes/macrophages. It is a disease similar to HIV in 
humans and the animal can be a carrier for months to years before symptoms start to show. The 
symptoms can be severe, arthritis being the most common for adult goats. 
This study aimed to find variations in the CCR5-gene that can affect the onset of disease, and 
to complement earlier studies. It also includes more different breeds, than previously studied. It 
was also to study the possibility of breeding as a control measure, for the disease. 
Blood samples and nose swabs from 127 goats were sequenced and analyzed. Four Swedish 
breeds were included; Swedish lantras, Göingegoat, Lappgoat and Jämtgoat. 
Two mutations were found, one that has previously been shown to possibly have an impact on 
pro-viral load. There were variations found, in the genotypes, between and within some of the 
breeds, especially for the breeds Jämtgoat and Göingegoat. There were differences found in 
genotype- and allele frequencies for the different breeds. This is the second only study on this 
subject, on Swedish goat breeds. 
No significant differences could be found in the correlation between genotype and prevalence 
of CAE, in the Swedish breeds, though the sample size of sero-positive animals was small. 
The genotype- and allele frequencies varied significantly between the breeds, making the 
possibility for breeding different, for each. Nothing conclusive could be said, in this study, about 
the possibility of breeding to contain CAE, but the frequencies could be a basis for further studies 
into the subject. More studies, with more sero-positive animals and increased sample size, need to 
be conducted.  
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Caprine Arthritis Encephalitis, or CAE, is a disease in goats that can negatively 
affect a whole farm. Diseased animals may have a negative influence on milk 
production (Martínez-Navalón et al., 2013 and Tariba et al., 2017). The disease is 
contagious and the owners have to cull all the infected animals to get rid of the 
disease.  
Cases of CAE are compulsory to report, in Sweden (to the Swedish Board of 
Agriculture). There are voluntary control programs in place around the world, 
including Sweden (Gård och Djurhälsan). Farms with small herds or indigenous 
breeds (allmogegetter in Sweden) may be wary of enrolling into the control 
program for fear of losing all their animals and genetic material, and because it 
can be too costly. 
CAE is a lentivirus, a sub-family of the retrovirus family. Together with MVV 
(Maedi-Visna virus) in sheep they form the group SRLV (small ruminant 
lentiviruses) (Leroux et al., 1995; Blacklaws, 2012). CAE usually affects the 
brain/nervous system in young animals (encephalitis, though rare) and, most 
commonly, the joints of adults (arthritis) (SVA, 2021; Patel et al., 2012). Other 
symptoms include pneumonia, mastitis and cachexia (emaciation).  
CAE and MVV strains have been shown to jump species between sheep and 
goat (Shah et al., 2004, Gjerset et al., 2007). SRLVs are transmitted primarily via 
colostrum and milk to the young (Blacklaws et al., 2004). It is also transmitted 
horizontally between individuals. It is thought to be mainly transmitted through 
aerosols, in those cases, but the exact transmission route is not established. An 
infected animal can be asymptomatic for months to years after infection, but can 
still transmit the disease, which makes it more difficult to contain (Blacklaws et 
al., 2004; Rowe & East, 1997). 
There is no effective treatment or vaccine for the disease, with some vaccines 
exacerbating the clinical symptoms (Patel et al., 2012). Control programs for 
SRLVs most commonly use the method of first separating the young directly after 
birth and feeding them treated colostrum/milk and keeping them separate from 
infected animals (Blacklaws et al., 2004; Reina et al., 2009). All animals will be 
regularly tested and culled if having a positive result.  
Another method is to test and separate animals into different herds and care for 
them separately, according to generation. The young of the infected animals will 
1. Introduction  
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be immediately separated after birth. The infected animals will then be phased out 
(Reina et al., 2009; Konishi et al., 2011). 
The gene looked at in this study is a variant of the CCR5 gene (C C chemokine 
receptor, type 5) and has been shown to increase the susceptibility to-, and 
expression of CAE, in the animal (Colussi et al., 2019). A variant of the gene has 
also been shown to play a part in resistance to infection of HIV, in humans 
(Kaslow et al., 2005), and SRLV in sheep (White et al., 2009).  
This study is a continuation of previous (student) work in which the resistance 
for CAE in the CCR5-gene, in goat, was studied (Gunnarsson, 2020).  
The aim of this study is to gather more data to validate previous results about 
the variation in the CCR5 gene and its effect on CAE. Also to include more 
breeds for examining in-breed and cross-breed variation/spread, of the gene-
variant.  
Breeding may be an addition to the programs existing today in containing the 




2.1. Small Ruminant lentiviruses 
Small ruminant lentiviruses include the diseases CAE and MVV. These were 
thought to be separate and species-specific. This has been rebuked and it has been 
shown that strains of the virus can jump species (Shah et al., 2004; Gjerset et al., 
2007; Patel et al., 2012), thus both being reclassified into the group Small 
ruminant lentiviruses (SRLV). 
There are two types of lentiviruses; one affecting both monocytes/macrophages 
and lymphocytes (as in BIV, HIV, FIV) while the other only affects the 
monocytes/macrophages (Patel et al., 2012). The SRLV lentiviruses only affect 
the monocyte/macrophage linage (Blacklaws, 2012; Leroux et al., 2010; Patel et 
al., 2012).  Thus these viruses are not immuno-suppressant, and the animal can 
still produce antibodies. 
Virus replication is induced during monocyte differentiation, as has been 
shown in sheep in a study by Gendelman et al. (1986).  The virus matures together 
with the monocytes, as they mature into macrophages. The virus shows the most 
expression at this maturation stage. 
Symptoms include pneumonia, arthritis, encephalitis and cachexia (SVA, 2021; 
Patel et al., 2012). Lesions will be formed in the affected tissue. The lungs and 
nervous system are mainly affected in MVV and the joints in CAE. 
 
2.1.1. Caprine Arthritis Encephalitis 
Caprine arthritis encephalitis (CAE) is a lentivirus, a genus of retroviruses, 
belonging to the same group as (among others) HIV in human, BIV in cattle and 
FIV in cats (Patel et al., 2012). CAE mainly infect goats. 
The virus does not act as an immunosuppressant like other lentiviruses (Leroux 
et al., 2010), thus the infected animals still show an immunological response. This 
is because the CAE virus affects only the macrophage line and not the 
lymphocytes (see earlier paragraph on SRLV). 
2. Literature review 
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Clinical symptoms include arthrithis, encephalitis, mastitis and cachexia (SVA, 
2021; Patel et al., 2012). Arthritis is the most common symptom in adult goats 
while encephalitis is most common in young animals. Lesions form in the affected 
tissue. 
Symptoms can take months to years to surface (SVA, 2021). However 
asymptomatic animals can still carry and transmit the disease.  
 
2.2. Transmission 
The main route of transmission is thought to be through colostrum and milk from 
infected animals (Blacklaws et al., 2004; Gjerset et al., 2007; Rowe & East, 1997; 
Shah et al., 2004). The disease can also be transmitted horizontally, between 
animals, such as in stables were animals are kept near to each other. The exact 
transmission is not clear but it is thought to be via aerosols, especially from 
animals with SRLVs affecting the lungs. Other routes of transmission include 
contact between mother and young directly after birth, milking equipment and via 
handlers (Blacklaws et al., 2004; Gjerset et al., 2007; Rowe & East, 1997; Shah et 
al., 2004).  
Transmission via semen from affected animals is not thoroughly studied. 
Though not many studies have been made, one study by Ahmad et al. (2012) has 
shown evidence for vertical transmission via AI from infected bucks. They used 
semen infected in vitro and showed that all embryos collected were free from 
CAE pro-viral DNA and could be used for embryo transfer. So it seems like 
embryos might not be affected by the virus. However some of the does had pro-
viral DNA in uterine smears/swabs, and could therefore potentially be infected 
from the semen.  
Transmission directly from pastures has so far not been shown, though the 
virus can be transmitted horizontally, as described earlier. 
Different strains of SRLVs have been shown to jump species (Shah et al., 
2004, Gjerset et al., 2007), mainly between sheep and goat.  
 
2.3. Milk production 
Of the studies found, most show no significant impact from CAE on total milk 
production (Kaba et al., 2012; Leitner et al., 2010 and Nord & Ådnøy, 1997). 
Two studies by Tariba et al. (2017) and Martínez-Navalón et al. (2013) did 
however show signs of a negative impact. The study by Kaba et al. (2012), a 
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cohort study made over a 12-year period, did show a significant difference in 
percentage of fat and lactose, between sero-positive and sero-negative animals. 
Nord & Ådnøy, (1997) used data from 1799 goats. They compared an ELISA 
test for CAE-antibodies with records of milk production. 
The study by Leitner et al., (2010) monitored one flock of 248 animals, for 
three consecutive years. The results did show a significant difference on the milk 
yield for the first lactation but none on the second to fourth lactation. 
Tariba et al. (2012) showed a significant difference in all parameters tested, 
including total milk yield and total amount of fat, protein and lactose. Blood- and 
milk samples were collected from 808 goats. 
Martínez-Navalón et al. (2013) did a retrospective study, with data on milk 




There is no effective treatment or vaccine for SRLV today (Patel et al., 2012). 
Attempts to develop vaccines have been made without good results, with some 
even worsening clinical symptoms. 
The main way of controlling the disease is through continuous testing and 
culling of infected animals, as well as removing the young directly after birth to 
avoid transmission between mother and young (Reina et al., 2009). The young are 
then given treated colostrum and milk.  
Another method is phasing out the disease by separating the herd into two 
flocks; infected and non-infected (Konishi et al., 2011; Reina et al., 2009). These 
animals are then kept separate from each other, and are continuously tested. This 
requires more work but can be a good alternative for small herds, or if they want 
to keep genetic material (such as for indigenous breeds with small populations). 
 
2.5. CCR5 
The CCR5-gene is located on chromosome 22. The position investigated in this 
project is in the promoter region (Colussi et al., 2019b). The promoter region is 
where gene transcription is initiated. The sequence studied is a part of the gene, 
position 779-1107. 
CCR5 is an important co-receptor for macrophage-tropic viruses to be able to 
enter into the host cell (Colussi et al., 2019) 
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The expression of the CCR5-gene has been shown to have an impact on the 
expression of the disease, and to aggravate clinical symptoms (Colussi et al., 
2019).  
The earlier works by Colussi et al. (2019) and Gunnarson (2020) showed a 
mutation at loci g1059.T, that Colussi et al. (2019) found could affect the increase 
of viral load. The mutation displayed a genotype (T’T’) that resulted in the 
increase. The same mutation has been explored in this study. 
For HIV, in human, a deletion of the gene showed great resistance to infection 
(Kaslow et al., 2005). The same has been seen for sheep (White et al., 2009), 
were pro-viral levels for deleted homozygotes were significantly reduced. 
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Samples from 127 goats of the Swedish breeds Swedish lantras (25 samples), 
Göingegoat (17), Lappgoat (7), Jämtgoat (50) and some unknown-/crossbreeds 
(28), were studied and analyzed. 72 samples were already sequenced before the 
study started while 55 (60 from the beginning) were sequenced during spring 
2021. All samples were collected beforehand. The samples were collected via 
nose swabs and/or blood samples. They were then sequenced and analyzed for the 
previously published mutation g1059.T (Colussi et al, 2019; Gunnarsson, 2020). 
The region of the part of the CCR5 gene sequenced was position 779-1107, in 
the promoter region of the Caprine reference sequence HQ650162.1 (Colussi et 
al., 2019b).  
The DNA-extraction, for the blood samples, was conducted according to the 
QIAprep ® Spin Miniprep Kit, Quick start protocol and QIAsymphony® DNA 
Handbook. The nose swabs had already been sequenced beforehand. 
The blood samples were then the put through NanoDrop to measure the 
concentration and later aliquots were done and a working solution diluted to 
4ng/µl. 
PCR was then conducted following the BigDye® Direct Cycle Sequencing Kit 
protocol and sequencing by capillary electrophoresis (BigDye direct sequencing 
assay). 
The sequences were read, as chromatograms, with the program FinchTV 
Version 1.4.0 (Geospiza 2008). Text files of the sequences were put through the 
web-program nucleotide BLAST (NCBI 2021), to compare them with each other 
and spot potential mutations. The results were compared to the chromatograms to 
confirm them. 
Genotype- and allele frequencies were calculated for all the samples 
collectively and for the respective breeds. 
𝐺𝑒𝑛𝑜𝑡𝑦𝑝𝑒𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 =  
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑔𝑒𝑛𝑜𝑡𝑦𝑝𝑒
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠
 
 
𝐴𝑙𝑙𝑒𝑙𝑒𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 =  
𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑎𝑙𝑙𝑒𝑙𝑒
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠𝑥2
 
 
Linkage disequilibrium was calculated to confirm genetic variation in the 
samples for two found mutations. It was calculated for all samples and the 
3. Methods and materials 
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different breeds with the web-program GenePop (Rousset, 2008). P-values were 
calculated. 
The genotypes, for both the mutations for the different breeds, were tested for 
Hardy Weinberg equilibrium. With the hypothesis; H0= the respective breeds are 
in HW-equilibrium. 
A Chi2-test was used to compare the correlations for the two mutations, in the 
whole sample set and between- and within the breeds. It was also used to calculate 
the correlation between genotype and instance of disease, for ten goats with 
confirmed CAE (sero-positive), from four farms that had at least one positive case 
of CAE. The Chi2 function in Excel and the Chi-square calculator from the web 
site Social Science Statistics was used for calculation.  
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Two different mutations were found (see appendix 2), one of which was the 
g1059.T mutation mentioned earlier, that has been shown to have a correlation 
with increased pro-viral loads (Colussi et al., 2019). This will further be named as 
“Mutation 1”. The other mutation found will further be named as “Mutation 2”. 
Table 1 shows the genotype frequencies for mutation 1 and 2 respectively.  Table 



















Mutation 1       
T’T’ 0.82 0.80 0.23 0.71 1.00 0.89 
T’C’ 0.16 0.20 0.59 0.29 0.00 0.11 
C’C’ 0.2 0.00 0.18 0.00 0.00 0.00 
Mutation 2       
A’A 0.40 0.64 0.06 0.71 0.30 0.50 
A’C’ 0.42 0.36 0.53 0.29 0.42 0.43 












4.  Results  
Table 1. Genotype frequencies for the two found mutations in the CCR5-gene. Separated for the 




















Mutation 1       
T’ 0.90 0.90 0.53 0.86 1.00 0.95 
C’ 0.10 0.10 0.47 0.14 0.00 0.05 
Mutation 2       
A’ 0.61 0.82 0.32 0.86 0.51 0.71 
C’ 0.39 0.18 0.68 0.14 0.49 0.29 
 
Jämtgoat was found to only exhibit the T’T’ genotype, for the first mutation, 
with an allele frequency of 100%. The genotypes were much more evenly spread 
for the second mutation, the same with the allele frequency (51% for A’ and 49% 
for C’).  
Göingegoat had the highest frequency for the C’C’ genotype, of the first 
mutation. It was also the same for the second mutation. There were also many 
heterozygotes for both of the mutations. 
Swedish lantras (and the Unknown group) had a high frequency of the T’T’ 
genotype. 
Lappgoat had genotype frequencies of 71% for T’T and 29% for T’C for the 
first mutation and the same for A’A and A’C respectively, for the second 
mutation. If combined with the results from Gunnarsson (2020) the frequencies 
were 61% for T’T’, 39% for T’C, 61 % for A’A’ and 39% for A’C’ (from a total 
of 18 individuals). 
 The allele frequencies in Lappgoat were 86% for T’, 14% for C’ (of the first 
mutation), and 86% for A’ and 14% for C’ (of the second mutation). Combined 
with Gunnarsson (2020) they were 81% for T’, 19% for C’ for the first mutation 








4.1. Linkage disequilibrium 
The result of the LD test showed that there was a significant correlation between 
the two mutations for all the breeds, except for Jämtgoat that could not be 
calculated. This since it only displayed one genotype for mutation 1. Contingency 
tables for LD, for the different breeds, and p-values can be seen in appendix 4  
The T’T genotype for mutation 1 was often paired with the A’A genotype of 
mutation 2. The same could be seen for the T’C’ genotype together with the A’C’ 




The test showed that the correlation between the two mutations were significant 
for all the samples combined as well as for within the breeds of Göingegoat, and 
the Unknown/Crossbreed (see table 3). 
The correlation between genotype and disease (CAE) was not significant, with 
a p-value of 0.97 for mutation 2 and 0.53 for the first mutation. The T’C’ & C’C’ 
genotypes were put together in the calculation, since there were so few with the 
C’C’ genotype. 
Observed and expected values, for the tests, can be found in appendix 3. 
 




















A CHI2-test was also done to see if there were significant differences between 
genotypes for mutation 1 between the breeds. The tests showed significant 
differences between Swedish lantras-Göingegoat, Swedish lantras-Jämtgoat, 
Göingegoat-Lappgoat, Göingegoat-Jämtgoat and Jämtgoat-Lappgoat. No 
significant difference was found between Swedish lantras and Lappgoat. See p-
values in table 4. 
 
Table 3. p-values for correlation between genotype and CAE, and for correlation between the 





















0.00028 0.0067 0.0276 0.00001 0.0032 0.63 
 
The test for HW equilibrium showed that all breeds were in equilibrium, for both 
of the mutations. Degree of freedom was one. All values were below the threshold 




Göingegoat Lappgoat Jämtgoat 
Mutation 1 0.31 0.20 0.21 0.00 






Table 4. p-values for mutation 1, between the different breeds 
Table 5.X2-valuesfor test of HW-equilibrium. 
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5.1. Milk production 
The loss of milk production from infected animals showed mixed results, in 
previous studies, however even if no direct losses on an individual level could be 
measured, there would still be a loss on the total production since the infected 
animals would be removed from the herd and culled. 
 
5.2. Treatment 
No treatments or vaccines are available today so alternative methods are crucial in 
containing CAE. It is both a production- and animal welfare issue. The control 
programs used today result in huge losses since many animals in affected herds 
need to be culled. There is also more work with separating the young and healthy 
from sick animals. Especially if the “phasing out” method mentioned earlier is 
used, since then several separate groups need to be looked after. More care is also 
needed so that the disease does not spread via handlers and equipment, in this 
case. Therefore breeding would be a good complement to existing methods, if it is 
viable. This will be discussed more later on in the text.  
5.3. CCR5 and CAE 
As in previous studies two mutations on the CCR5 gene were found (Colussi et 
al., 2019 & Gunnarsson, 2020). There were significant differences between the 
mutations within the breeds Göingegoat and the Unknown/Crossbreeds, and 
within all the samples, as shown in the result section (table 3). There were some 
significant differences for the first mutation between the breeds, except for 
between Swedish lantras-Lappgoat. Many of the animals, who were heterozygous, 
were as such on both mutation loci. This indicates that these mutations are 




effect the second mutation has on CAE is not known. Since the effect of the 
second mutation is unknown the focus has been on mutation 1, in this study, as it 
has proven to be of interest from previous studies. 
The C’C’ combination of the first mutation seemed the most prevalent in 
Göingegoat, compared to all the other breeds. 
Ten of the sampled animals were confirmed carriers of CAE (sero-positive). 
The chi2-test showed no significant difference between genotype and prevalence 
of disease for both of the mutations. Only the herds that had at least one case of 
CAE were included in the calculations, since it was not possible to know if 
animals from the other herds had been subjected to the virus or not. Therefore 
they would not be a fair representation. 
In other studies the prevalence of the first mutation (T’T’) had an impact on 
pro-viral levels (Colussi et al., 2019). In their study they showed that the T’T’ 
genotype increased the pro-viral load while it was the opposite for the C’C’ 
genotype. However Gunnarsson (2020) could not find any significant correlation 
between the mutation and prevalence of disease for any of the mutations, as was 
the case in this study. Gunnarsson (2020) studied two breeds with a total of 96 
samples. In this study there were four breeds studied with a total of 127 samples, 
broadening the study material, as was the aim of this study. 
The correlation between the first mutation and CAE could not be proven in the 
study presented here. Since in this study only ten of the animals were confirmed 
sero-positive more samples need to be studied to reach any conclusive results. 
 All Jämtgoat included in this study were homozygous for the first mutation 
(T’T’). If previous results hold that this mutation could increase the viral load, 
then this breed might be more susceptible to CAE, assuming that we included a 
representative sample from the entire population. Similarly Göingegoat might be 
more resistant to the disease since most of them were either homozygous for 
mutation 1 (C’C’) or heterozygous (T’C’). More studies need to be conducted on 
this to reach any conclusions. 
The breeds were chosen based on the fact that mostly Swedish lantras had been 
studied previously (and some Lappgoats) (Gunnarsson (2020). Gunnarsson had 
samples from 85 Swedish lantras and 11 Lappgoats. In this study samples from 25 
Swedish lantras, 17 Göingegoats, 7 Lappgoats and 50 Jämtgoats were analyzed. 
The indigenous breeds (primarily Göingegoat and Lappgoat) have small 
populations, thus fewer samples were possible to collect. Samples from Jämtgoat 
were easier to collect since more were available. That is why there were more 
samples of Jämtgoat, and fewer from the other breeds.  
The breeds should be well represented since they are from several different 
herds, from across the country. Jämtgoat-samples were collected both from herds 
with a focus on milk production and those with a focus on preserving the breed. 
Farms with Göingegoat and Lappgoat are mainly focused on breed-preservation. 
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With Swedish lantras it is hard to know if the incidence of disease is because of 
genetic factors or because so many of those herds have been actively working 
with prevention programs. They have conducted continuous testing, separating the 
young at birth and culled infected animals. 
The allele frequency of C’, of the first mutation, for Swedish lantras was 10% 
in this study compared to the study of Gunnarsson (2020) with a frequency of 
14%. For Lappgoat the frequency, for the same allele, was 14% and 23% 
respectively, though there are only seven samples in this study. The differences in 
allele frequencies were significant in both studies. Lappgoat showed a higher 
frequency of the C’ allele than Swedish lantras did. 
It might be viable to breed on the first mutation in the future but the connection 
between the CCR5-gene and the previously studied casein gene, CSN1S1, 
(Gunnarsson, 2020) is not known. It is also not known if other genes play a role in 
expression of/susceptibility to CAE.  
More studies have to be done before these results can be used for breeding, as 
there is no conclusive correlation between these mutations and CAE, in Swedish 
goats, yet.  
The basis for breeding on the mutation is different for the breeds. It should be 
easier on Göingegoat since they have the most variation and the most of the T’C’ 
and C’C’ genotype, for the first mutation. In Jämtgoat, however, it might be 
impossible since none of the individuals in this study showed any other variation 
than the T’T’ genotype. There will have to be more samples taken to seek 
variation in genotype for this breed. If one is found then it might be possible to 
breed on it, but not as it looks now. 
Right now there is not enough data to support the link between the mutation on 
the CCR5 gene and expression of CAE in Swedish goats. Only a few samples (10) 
could be used to analyze this link. Other, unknown, genes might also factor into 
the onset and expression of the disease.  
The deletion of the gene had showed increased resistance both for HIV in 
human and for sheep (Kaslow et al., 2005 & White et al., 2009). The gene is co-
receptor that enables macrophage-tropic viruses to enter the host cells (Colussi et 
al., 2019). It might be this that makes the CCR5 gene important when it comes to 
expression of the CAE virus, as it is a macrophage-tropic virus. Have not found 
anything on if the deletion of this gene would affect other parts of the immune 
system. 
Animals with CAE can still produce antibodies as this disease does not affect 
the T-cells, and are not immuno-suppressant (Leroux et al., 2010). So even if they 
produce antibodies they can still be sick/infected and develop symptoms. As well 
as transmit the disease.  
If breeding becomes a viable option in containing the disease it could be a 
helpful tool, together with existing control programs. If the disease could be 
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further contained it would decrease production losses connected to it. It would 
also increase animal welfare, since it is a disease with severe symptoms that leads 
to suffering and the animal ultimately being culled. Containing it would also 
decrease the risk of losing breeds/genetic materials from being forced to cull sick 
animals. All this would also improve the economic aspect of the production, with 









There were no significant correlations found between genotype and prevalence of 
disease, but only ten animals were sero-positive. More studies need to be 
conducted, and more animals tested for CAE, to increase the sample size and the 
validity. More animals of all Swedish breeds need to be sampled, especially for 
the indigenous breeds. 
There were significant differences in genotype within and between some of the 
breeds for the mutation. 
There were big differences in genotype- and allele frequencies. Breeding 
would therefore be easier on some breeds, since they show more variation in 
genotype. 
This study show genotype- and allele frequencies for the Swedish goat breeds 
and can be used as a basis for further studies on the correlation between them and 
instance of CAE. 
More needs to be studied before the possibility of breeding as a way of 
stopping the disease.  
In the future, if breeding becomes a viable method, this might be used to 
increase the chance of containing the disease and therefore positively affect 
production and animal welfare. 
Right now there is not enough data to support the link between the mutation on 
the CCR5 gene and expression of CAE in Swedish goats. Other, unknown, genes 
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List of genotypes for all individuals, used in GenePop for LD. 0101=A’A’, 0102=A’C’, 
0202=C’C’ for mutation 2. 0303=T’T’, 0304=T’C’, 0404=C’C’ for mutation 1. 
CCR5 Goat LD 
     Loc1, Loc2 
POP 
001, 0101  0303                              
002, 0102  0304 
003, 0102  0304 
004, 0101  0303 
005, 0102  0303 
006, 0101  0303 
007, 0102  0304 
008, 0101  0303 
009, 0101  0303 
010, 0101  0303 
011, 0102  0304 
012, 0202  0304 
013, 0101  0303 
014, 0102  0303 
015, 0102  0303 
016, 0101  0303 
017, 0101  0303 
018, 0102  0303 
019, 0102  0303 
020, 0101  0303 
021, 0101  0303 
023, 0102  0304 
024, 0102  0304 
026, 0102  0303 
027, 0101  0303 
028, 0202  0303 
029, 0101  0303 
030, 0102  0303 
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031, 0101  0303 
033, 0101  0303 
034, 0101  0303 
035, 0101  0303 
036, 0101  0303 
037, 0101  0303 
038, 0101  0303 
040, 0101  0303 
041, 0102  0303 
042, 0101  0303 
044, 0202  0304 
045, 0102  0303 
046, 0102  0303 
047, 0102  0303 
048, 0101  0303 
049, 0101  0303 
050, 0101  0303 
051, 0102  0303 
052, 0101  0303 
053, 0101  0303 
054, 0102  0303 
055, 0101  0303 
056, 0101  0303 
057, 0102  0303 
058, 0102  0303 
059, 0102  0303 
060, 0101  0303 
061, 0102  0304 
062, 0101  0303 
063, 0102  0304 
064, 0101  0303 
065, 0101  0303 
066, 0101  0303 
067, 0101  0303 
068, 0102  0304 
069, 0102  0303 
070, 0102  0304 
071, 0202  0404 
072, 0202  0404 
073, 0102  0304 
074, 0102  0304 
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075, 0202  0304 
076, 0102  0304 
077, 0102  0303 
078, 0202  0304 
079, 0202  0404 
080, 0102  0303 
081, 0202  0304 
082, 0101  0303 
083, 0102  0304 
084, 0202  0304 
085, 0102  0303 
086, 0202  0303 
087, 0202  0303 
088, 0102  0303 
089, 0102  0303 
090, 0101  0303 
091, 0102  0303 
092, 0202  0303 
093, 0101  0303 
094, 0102  0303 
095, 0101  0303 
096, 0202  0303 
097, 0102  0303 
098, 0202  0303 
099, 0102  0303 
100, 0101  0303 
101, 0101  0303 
102, 0102  0303 
103, 0202  0303 
104, 0102  0303 
105, 0101  0303 
106, 0202  0303 
107, 0102  0303 
108, 0102  0303 
109, 0101  0303 
110, 0102  0303 
111, 0202  0303 
112, 0102  0303 
113, 0102  0303 
114, 0102  0303 
115, 0102  0303 
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116, 0202  0303 
117, 0101  0303 
118, 0101  0303 
119, 0202  0303 
120, 0102  0303 
121, 0102  0303 
122, 0102  0303 
123, 0202  0303 
124, 0202  0303 
125, 0101  0303 
126, 0101  0303 
127, 0101  0303 
128, 0101  0303 
129, 0202  0303 
130, 0102  0303 
131, 0101  0303  



























Sequence for a homozygote on both mutation loci. Red is mutation 2(C’C’), gold is mutation 
1(T’T’). 













         
          
          
          
          
          
          
Sequence for a heterozygote on both mutation loci. Red is mutation 2(A’C’), gold is mutation 
1(T’C’). 














        
        








































Observed and expected values for Chi2-test of mutation 1 and mutation 2, respectively, in 
correlation with prevalence of CAE. 
Observed value T'T' T'C' C'C' Total 
Disease 9 1 0 10 
No disease 22 5 0 27 
Total 31 6 0 37 
Expected value T'T' T'C' C'C' Total 
Disease 8.38 1.62 0 10 
No disease 22.62 4.38 0 27 
Total 31 6 0 37 
 
Observed value A'A' A'C'  C'C' Total 
Disease 6 3 1 10 
No disease 16 10 1 27 
Total 22 13 2 37 
Expected value A'A' A'C'  C'C' Total 
Disease 5.94 3.51 0.54 10 
No disease 16.06 9.49 1.46 27 







T’T T’C’ C’C’ Total 
A’A’ 51 0 0 51 
A’C’ 38 15 0 53 
C’C’ 14 6 3 23 
Total 103 21 3 127 
Expected value T’T T’C’ C’C’ Total 
A’A’ 41.36 8.44 1.21 51 
A’C’ 42.98 8.76 1.25 53 
C’C’ 18.66 3.8 0.54 23 







T’T T’C’ C’C’ Total 
A’A’ 16 0 0 16 
A’C’ 4 5 0 9 
C’C’ 0 0 0 0 
Total 20 5 0 25 
Expected value T’T T’C’ C’C’ Total 
A’A’ 12.8 3.2 0 16 
A’C’ 7.2 1.8 0 9 
C’C’ 0 0 0 0 








Observed and expected values for chi2-test for correlation between the genotypes of the two 








T’T T’C’ C’C’ Total 
A’A’ 1 0 0 1 
A’C’ 3 6 0 9 
C’C’ 0 4 3 7 
Total 4 10 3 17 
Expected value T’T T’C’ C’C’ Total 
A’A’ 0.23 0.59 0.18 1 
A’C’ 2.12 5.29 1.59 9 
C’C’ 1.65 4.12 1.23 7 





T’T T’C’ C’C’ Total 
A’A’ 5 0 0 5 
A’C’ 0 2 0 2 
C’C’ 0 0 0 0 
Total 5 2 0 7 
Expected value T’T T’C’ C’C’ Total 
A’A’ 3.57 1.43 0 5 
A’C’ 1.43 0.57 0 2 
C’C’ 0 0 0 0 
Total 5 2 0 7 
Observed value 
(Jämtgoat) 
T’T T’C’ C’C’ Total 
A’A’ 15 0 0 15 
A’C’ 19 1 0 20 
C’C’ 13 0 0 13 
Total 47 1 0 48 
Expected value T’T T’C’ C’C’ Total 
A’A’ 14.69 0.31 0 15 
A’C’ 19.58 0.42 0 20 
C’C’ 12.73 0.27 0 13 







T’T T’C’ C’C’ Total 
A’A’ 15 0 0 15 
A’C’ 11 1 0 12 
C’C’ 1 2 0 3 
Total 27 3 0 30 
Expected value T’T T’C’ C’C’ Total 
A’A’ 13.5 1.5 0 15 
A’C’ 10.8 1.2 0 12 
C’C’ 2.7 0.3 0 3 

















Mutation 2/Mutation 1 T’T’ T’C’ C’C’ Total 
A’A’ 51 0 0 51 
A’C’ 38 15 0 53 
C’C’ 14 6 3 23 
Total 103 21 3 127 
 
Mutation 2/Mutation 1 T’T’ T’C’ C’C’ Total 
A’A’ 16 0 - 16 
A’C’ 4 5 - 9 
C’C’ - - - - 
Total 20 5 - 25 
Mutation 2/Mutation 1 T’T’ T’C’ C’C’ Total 
A’A’ 1 0 0 1 
A’C’ 3 6 0 9 
C’C’ 0 4 3 7 
Total 4 10 3 17 
Mutation 2/Mutation 1 T’T’ T’C’ C’C’ Total 
A’A’ 5 0 - 5 
A’C’ 0 2 - 2 
C’C’ - - - - 
Total 5 2 - 7 
Appendix 4 
Contingency table for genotypic disequilibrium, for all samples. 
Contingency table for genotypic disequilibrium,, for Swedish lantras 
Contingency table for genotypic disequilibrium,, for Göingegoat 
 
Contingency table for genotypic disequilibrium,, for Lappgoat 
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Mutation 2/Mutation 1 T’T’ T’C’ C’C’ Total 
A’A’ 15 0 - 15 
A’C’ 21 0 - 21 
C’C’ 14 0 - 14 
Total 50 0 - 50 
Mutation 2/Mutation 1 T’T’ T’C’ C’C’ Total 
A’A’ 15 0 - 15 
A’C’ 10 1 - 11 
C’C’ 0 2 - 2 











p-value 0.00 0.002 0.029 0.046 - 0.009 
 
Contingency table for genotypic disequilibrium,, for Jämtgoat 
Contingency table for genotypic disequilibrium,, for Unknown/Crossbreeds 
 p-values for LD 
